DBV Technologies Shares Fall After 2024 Loss Widens

MT Newswires Live
03-25

DBV Technologies (DBVT) shares fell 1.5% in recent Monday trading after the company reported that full-year 2024 losses widened to $1.17 per diluted share from $0.76 a year earlier.

A single analyst polled by FactSet expected a loss of $0.98.

As expected, no revenue for the year ended Dec. 31 was reported.

As of Dec. 31, the company said it had $32.5 million in cash and cash equivalents, and expected it could fund operations through April.

The company also announced the US Food and Drug Administration agreed with its proposal to consider the safety exposure data from the Vitesse Phase 3 study for Viaskin peanut patch in children aged four to seven years for a biologics license application filing in this age group.

This expedites the submission of the application to H1 2026 and accelerates the potential launch of the product by a year if approved. The FDA's decision also eliminates the need to conduct the Comfort Children supplemental safety study, the company said.

Price: 4.54, Change: -0.07, Percent Change: -1.52

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10